Showing results (1571-1580 of 3,473) with videos related to
Sort By:
Pageof 348
Clinical Pharmacokinetics|September 1, 1989
Relationship of bioelectrical impedance to pharmacokinetic parameters of theophylline in healthy malesB J Zarowitz, E Peterson, J PopovichClinical Pharmacokinetics|October 11, 2016
Disease-Drug Interaction of Sarilumab and Simvastatin in Patients with Rheumatoid ArthritisEun Bong Lee, Nikki Daskalakis, Christine Xu, et al.Clinical Pharmacokinetics|October 17, 2016
Lack of Clinical Pharmacokinetic Studies to Optimize the Treatment of Neglected Tropical Diseases: A Systematic ReviewLuka Verrest, Thomas P C DorloClinical Pharmacokinetics|October 19, 2016
Clinical Determinants of Target Non-Attainment of Linezolid in Plasma and Interstitial Space Fluid: A Pooled Population Pharmacokinetic Analysis with Focus on Critically Ill PatientsIris K Minichmayr, André Schaeftlein, Joseph L Kuti, et al.Clinical Pharmacokinetics|January 16, 2008
Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in healthy subjectsSophie L Stocker, Kenneth M Williams, Andrew J McLachlan, et al.Clinical Pharmacokinetics|March 1, 2008
Should the currently recommended twice-daily dosing still be considered the most appropriate regimen for treating MRSA ventilator-associated pneumonia with vancomycin?Federico Pea, Pierluigi VialeClinical Pharmacokinetics|March 1, 2008
Population pharmacokinetics and pharmacodynamics of rivaroxaban--an oral, direct factor Xa inhibitor--in patients undergoing major orthopaedic surgeryWolfgang Mueck, Bengt I Eriksson, Kenneth A Bauer, et al.Clinical Pharmacokinetics|October 5, 2016
Clinical Pharmacokinetics and Pharmacodynamics of Insulin Glargine 300 U/mLJennifer N Clements, Tiffaney Threatt, Eileen Ward, et al.Clinical Pharmacokinetics|February 2, 2017
Population Pharmacokinetic Model and Pharmacokinetic Target Attainment of Micafungin in Intensive Care Unit PatientsLisa C Martial, Rob Ter Heine, Jeroen A Schouten, et al.Clinical Pharmacokinetics|October 28, 2018
Impact of CYP3A4*22 on Pazopanib Pharmacokinetics in Cancer PatientsSander Bins, Alwin D R Huitema, Pim Laven, et al.Pageof 348